What factors do you use to determine whether to add brachytherapy to EBRT for IIIC endometrial cancer?
Current NCCN guidelines suggest that vaginal brachytherapy is optional, and there may be concern for over-treatment locally given competing risk of distant metastatic disease.
3 Answers
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on
My philosophy is to use 45 Gy in 25 fractions of EBRT followed by two fractions HDR boost.
Join for free or sign in to see the full answer
Mednet Member
Radiation Oncology · Ohio State University
Answered on
Nothing in the way of prospective data, but an NCDB analysis showed a survival benefit in adding brachy to EBRT for patients with cervical gland/stromal involvement
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · University of Minnesota Medical School
Answered on
We would tailor the external beam dose and brachytherapy to the factors identified on the pathology report. IIIC covers many situations.
For a tumor up at the fundus, and grade 1 we might treat with external beam therapy alone and omit the brachytherapy.
If there was evidence of parametrial extensi...
Join for free or sign in to see the full answer